| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/10/1998 | CA2226695A1 H2-m modified transgenic animals |
| 07/10/1998 | CA2219960A1 Cdna clone he8cs41 that encodes a novel 7-transmembrane receptor |
| 07/09/1998 | WO1998029730A1 Method and apparatus for selective depletion of biological particles |
| 07/09/1998 | WO1998029555A2 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 07/09/1998 | WO1998029548A1 Human mage-like protein |
| 07/09/1998 | WO1998029543A1 Compounds for modulating cell negative regulations and biological applications thereof |
| 07/09/1998 | WO1998029537A2 Method for protecting plants |
| 07/09/1998 | WO1998029534A1 Method for activating human antigen presenting cells, activated human antigen presenting cells, and use of the same |
| 07/09/1998 | WO1998029533A1 Vectors and methods for the mutagenesis of mammalian genes |
| 07/09/1998 | WO1998029532A1 A method of oocyte enucleation and production of reconstituted embryos |
| 07/09/1998 | WO1998029452A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use |
| 07/09/1998 | WO1998029441A1 Human galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | WO1998029440A1 Mouse galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | WO1998029439A1 Galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | WO1998029432A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
| 07/09/1998 | WO1998029431A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport |
| 07/09/1998 | WO1998022574A3 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates |
| 07/09/1998 | WO1998021334A3 Antibody mg1 recognizing a small subset of human hematopoietic cells |
| 07/09/1998 | WO1998021320A3 Tissue type plasminogen activator (t-pa) variants: compositions and methods of use |
| 07/09/1998 | WO1998017796A3 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 07/09/1998 | WO1998008542A3 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 07/09/1998 | CA2282662A1 Human galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | CA2276745A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
| 07/09/1998 | CA2276529A1 Vectors and methods for the mutagenesis of mammalian genes |
| 07/09/1998 | CA2275975A1 Human mage-like protein |
| 07/09/1998 | CA2275854A1 Method for protecting plants |
| 07/09/1998 | CA2275538A1 Mouse galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | CA2275465A1 Galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | CA2274955A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as bartter's syndrome and gitelman's syndrome |
| 07/08/1998 | EP0852144A2 Enhancing keratinocyte migration and proliferation |
| 07/08/1998 | EP0852011A1 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc |
| 07/08/1998 | EP0851934A1 Plants which synthesise a modified starch, process for the production thereof and modified starch |
| 07/08/1998 | EP0851932A1 Plasmid stabilization |
| 07/08/1998 | EP0851929A1 CYTIDINE DEAMINASE cDNA AS A POSITIVE SELECTABLE MARKER FOR GENE TRANSFER, GENE THERAPY AND PROTEIN SYNTHESIS |
| 07/08/1998 | EP0851927A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/08/1998 | EP0851925A1 Human growth hormone variants |
| 07/08/1998 | EP0851921A1 Genetic alterations related to familial alzheimer's disease |
| 07/08/1998 | EP0851920A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their porduction |
| 07/08/1998 | EP0851917A1 Heterologous protein production system using avian cells |
| 07/08/1998 | EP0851876A1 Antisecretory factor peptides regulating pathological permeability changes |
| 07/08/1998 | EP0851875A2 Dna sequences and secreted proteins encoded thereby |
| 07/08/1998 | EP0851874A1 Novel variants of green fluorescent protein, gfp |
| 07/08/1998 | EP0851869A1 Breast specific genes and proteins |
| 07/08/1998 | EP0851767A1 Transcytosis vehicles and enhancers for drug delivery |
| 07/08/1998 | EP0851764A1 Heat shock protein-based vaccines and immunotherapies |
| 07/08/1998 | EP0812351A4 Three-dimensional cartilage cultures |
| 07/08/1998 | EP0763058A4 -i(RPS) GENE FAMILY, PRIMERS, PROBES, AND DETECTION METHODS |
| 07/08/1998 | EP0671004B1 Allergen/inflammatory testing and diagnosis |
| 07/08/1998 | EP0667959A4 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE -g(b)-AMYLOID PEPTIDE. |
| 07/08/1998 | EP0619841B1 T-cadherin adhesion molecule |
| 07/08/1998 | EP0583339B1 Stabilized enzymes and detergent compositions |
| 07/08/1998 | EP0528931B1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
| 07/08/1998 | CN1186695A Recombinant coccidiosis vaccines |
| 07/08/1998 | CN1039031C Method of gene transfer into plants |
| 07/07/1998 | US5777093 cDNAs associated with ataxia-telangiectasia |
| 07/07/1998 | US5777084 Antibody BV10A4H2 specific for human FLT3/FLK2 receptor and mybridoma |
| 07/07/1998 | US5777074 Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
| 07/07/1998 | US5776910 Dna molecule codes and fc receptors |
| 07/07/1998 | US5776889 Pathogen resistance |
| 07/07/1998 | US5776778 Growth factor preparation of thymocyte cell culture medium its production and use |
| 07/07/1998 | US5776773 Yeast artificial chromosomes and their use in the control of gene expression |
| 07/07/1998 | US5776760 Glyphosate tolerant plants |
| 07/07/1998 | US5776759 Polynucleotide sequences |
| 07/07/1998 | US5776748 Method of formation of microstamped patterns on plates for adhesion of cells and other biological materials, devices and uses therefor |
| 07/07/1998 | US5776747 Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer |
| 07/07/1998 | US5776743 Method of sensitizing tumor cells with adenovirus E1A |
| 07/07/1998 | US5776734 DNA encoding the β subunit of a mammalian maxi-K potassium channel |
| 07/07/1998 | US5776732 Isolated, purified polynucleotide sequence encoding a polypeptide |
| 07/07/1998 | US5776729 Human G-protein receptor HGBER32 |
| 07/07/1998 | US5776725 Recombinant production of glucagon receptors |
| 07/07/1998 | US5776717 IκB kinases |
| 07/07/1998 | US5776704 Method of detecting angiogenic protein |
| 07/07/1998 | US5776456 Administering a polypeptide |
| 07/07/1998 | US5776451 Use of interleukin-10 in adoptive immunotherapy of cancer |
| 07/07/1998 | CA2114416C Retroviral vectors containing internal ribosome entry sites |
| 07/07/1998 | CA1339938C Vectors and compounds for direct expression of activated human protein c |
| 07/02/1998 | WO1998028442A1 Methods for detecting and inhibiting the rna component of telomerase |
| 07/02/1998 | WO1998028435A1 Plant clones containing elevated secondary metabolite levels |
| 07/02/1998 | WO1998028432A1 A method of enhancing the rate of transfection of cells |
| 07/02/1998 | WO1998028430A1 Methods for producing parthenocarpic or female sterile transgenic plants |
| 07/02/1998 | WO1998028426A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 07/02/1998 | WO1998028425A1 Mammalian cytokine related to il10 |
| 07/02/1998 | WO1998028424A2 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 07/02/1998 | WO1998028417A1 Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells |
| 07/02/1998 | WO1998028406A1 Method and device for microinjection of macromolecules into non-adherent cells |
| 07/02/1998 | WO1998028334A1 Peptide antagonists of dp transcription factors |
| 07/02/1998 | WO1998028331A2 A variant human alpha-7 acetylcholine receptor subunit, and methods of production and use thereof |
| 07/02/1998 | WO1998028317A2 Synthesis of nucleosides and polynucleotides |
| 07/02/1998 | WO1998027995A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells |
| 07/02/1998 | WO1998027994A1 Proteins and compositions for modulating mitosis |
| 07/02/1998 | WO1998027932A2 Cerebellum and embryo specific protein |
| 07/02/1998 | CA2275964A1 Synthesis of nucleosides and polynucleotides |
| 07/02/1998 | CA2275892A1 Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells |
| 07/02/1998 | CA2275540A1 Cerebellum and embryo specific protein |
| 07/02/1998 | CA2275474A1 Method and device for microinjection of macromolecules into non-adherent cells |
| 07/02/1998 | CA2275436A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells |
| 07/02/1998 | CA2275180A1 A variant human alpha-7 acetylcholine receptor subunit, and methods of production and use thereof |
| 07/02/1998 | CA2275138A1 Mammalian cytokine related to il10 |
| 07/02/1998 | CA2274734A1 Proteins and compositions for modulating mitosis |
| 07/02/1998 | CA2274586A1 Methods for detecting and inhibiting the rna component of telomerase |